| Institution: | 1. Vichem Chemie Research Ltd, Herman, Budapest, Hungary;2. Microbial Pathogenesis, Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland;3. Now at: 1st Department of Internal Medicine, University of Cologne, Cologne, Germany;4. Institute of Infectious Disease and Molecular Medicine & Department of Pathology, University of Cape Town, MRC/NHLS/UCT Molecular Mycobacteriology Research Unit & DST/NRF Centre of Excellence for Biomedical TB Research, South Africa;5. Faculty of Natural Sciences, Department of Biochemistry, Comenius University in Bratislava, Bratislava, Slovakia;6. Microbiology and Microsystems, Global Health Institute, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland;7. Departamento de Microbiología, Facultad de Medicina, Universidad de Zaragoza, and Fundación ARAID, Zaragoza, Spain;8. CIBERES, Instituto de Salud Carlos III, Madrid, Zaragoza, Spain;9. Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden;10. Institute of Chemical Sciences and Engineering (ISIC), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland;11. Alere (San Diego), San Diego, CA, USA;12. Center for Infection and Immunity, Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université de Lille, Lille, France;13. Interdisciplinary Centre for Electron Microscopy, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland;14. Microbial Pathogenesis, Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, Lausanne, SwitzerlandThese authors contributed equally to this work: co‐first author.Co‐senior author. |
